Diabetes is a chronic condition that affects millions of people worldwide, characterized by impaired blood sugar regulation. Over time, elevated blood sugar levels can lead to severe complications such as cardiovascular disease, nerve damage, kidney failure, and vision loss. A less frequently discussed but crucial contributor to diabetes progression is chronic low-grade inflammation. This persistent inflammation worsens insulin resistance and damages the pancreatic beta cells responsible for producing insulin.
Research has shown that individuals with diabetes often exhibit elevated levels of inflammatory biomarkers such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). These markers not only indicate inflammation but also highlight its role as a driving factor in the development and progression of diabetes.
(References: [1] Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; [2] Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011)
Polyphenols, a diverse group of naturally occurring compounds found in plants, have gained attention for their powerful antioxidant and anti-inflammatory properties. Scientific studies suggest that polyphenols may directly address several mechanisms involved in diabetes management:
(References: [3] Aguirre L, Arias N, Macarulla MT, et al. Beneficial effects of quercetin on obesity and diabetes. Open Nutr J. 2011)
(References: [4] Henagan TM, et al. Polyphenols and gut health in diabetes. Curr Opin Clin Nutr Metab Care. 2015)
(References: [5] Cani PD, et al. Gut microbiota and metabolic syndrome. Nature. 2007)
ACEND incorporates a range of polyphenols that specifically target chronic inflammation and pathways associated with diabetes. Here’s how these ingredients contribute:
(References: [6] Lin YL, et al. Luteolin prevents inflammation-linked metabolic dysfunction. J Nutr Biochem. 2016)
(References: [7] Hanhineva K, et al. Impact of dietary polyphenols on carbohydrate metabolism. Mol Nutr Food Res. 2010)
(References: [8] Aggarwal BB, et al. Curcumin as an anti-inflammatory agent. J Clin Immunol. 2013)
Polyphenols in ACEND are metabolized by gut microbiota into bioactive compounds such as urolithins, phenolic acids, and short-chain fatty acids (SCFAs). These metabolites have significant benefits:
(References: [9] Zhao L, et al. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. J Diabetes. 2019)
Polyphenols in ACEND are carefully chosen to address key inflammatory biomarkers associated with diabetes:
(References: [10] Lee J, et al. Inflammatory biomarkers and diabetes management. Trends Endocrinol Metab. 2011)
Polyphenols in ACEND work through multiple mechanisms to deliver their health benefits:
ACEND is a clinically designed medical food that addresses the interconnected factors of chronic inflammation, gut health, and metabolic dysfunction. By combining a scientifically validated range of polyphenols, prebiotics, and essential nutrients, ACEND offers a holistic approach to mitigating diabetes progression. Its formulation is tailored to:
Polyphenols represent a promising, natural strategy for managing diabetes. Their ability to reduce inflammation, enhance gut health, and regulate glucose metabolism makes them a critical component of any comprehensive diabetes care plan. ACEND harnesses the power of polyphenols, positioning itself as a leader in the fight against chronic inflammation and its role in diabetes and other diseases. With ACEND, individuals can take a proactive approach to better health, leveraging the synergy of science and nature.
(References: [11] Panickar KS. Beneficial effects of dietary polyphenols in metabolic disorders. Mol Nutr Food Res. 2013)